Clinical and Developmental Immunology · 2007 · 320 citations · 27 references
Life SciencesImmunologyPsychiatryInflammationNeuroimmunologyPsychoneuroimmunologyAntidepressant PharmacotherapyAntidepressant TherapyCytokine BiologyCytokine RegulationCytokine SignalingDepression PharmacotherapyAnti-inflammatory MechanismsImmunomodulatory CytokinesImmunomodulatory EffectsInflammatory Cytokine NetworksInflammatory Mechanisms In DepressionInterleukin-mediated InflammationMajor DepressionProinflammatory Mediators
The specific associations between antidepressant treatment and alterations in the levels of cytokines remain to be elucidated. In this study, we aimed to explore the role of IL-2, IL-4, IL-12, TNF-alpha, TGF-beta1, and MCP-1 in major depression and to investigate the effects of sertraline therapy. Cytokine and chemokine levels were measured at the time of admission and 8 weeks after sertraline treatment. Our results suggest that the proinflammatory cytokines (IL-2, IL-12, and TNF-alpha) and MCP-1 were significantly higher, whereas anti-inflammatory cytokines IL-4 and TGF-beta1 were significantly lower in patients with major depression than those of healthy controls. It seems likely that the sertraline therapy might have exerted immunomodulatory effects through a decrease in the proinflammatory cytokine IL-12 and an increase in the anti-inflammatory cytokines IL-4 and TGF-beta1. In conclusion, our results indicate that Th1-, Th2-, and Th3-type cytokines are altered in the depressed patients and some of them might have been corrected by sertraline treatment.
27
Th1, Th2, and Th3 cytokine alterations in major depression
Aye-Mu Myint, B LEONARD, Hellen Steinbusch et al. · Journal of Affective Disorders · 2005 · 374 citations